Azienda Ospedaliera S. Croce e Carle, Via Michele Coppino 26, Cuneo, Italy.
Blood Transfus. 2010 Oct;8(4):255-9. doi: 10.2450/2009.0129-09.
Autologous or allogenic platelet gel is a blood component that exploits the effects of the cytokines contained in platelet α granules to stimulate repair processes. The properties of platelet gel were first tested on chronic ulcers to accelerate healing and later in orthopaedic, dental, vascular and cardiothoracic surgery. In our centre, we have been using platelet gel for 5 years, first for surgical patients with difficult wounds, then for orthopaedic patients undergoing osteosynthesis surgery and patients with ulcers not responding to traditional therapies. Subsequently we decided to extend the use of platelet gel also to amputations or traumatic loss of tissue of fingers.
In this article we present the results obtained over 5 years concerning 115 patients with finger amputations or wounds treated with platelet gel in our Service of Transfusion Medicine. Platelets were obtained fom allogeneic buffy coats (10 mL) and the gel was produced by adding thrombin to concentrated platelets. The decision to use homologous platelet gel was based on its limited cost, ease of preparation, almost unlimited availability, the fact that the number of platelets that can be collected is much higher than the therapeutic range and so able to replace the losses due to secondary medication, and last, but not least, it causes no discomfort to patients. The safety of the product was ensured by virology tests including molecular biology studies.
The recovery of soft tissue in all patients ranged from 80 to 100%; the median time for this recovery was 3 weeks (range, 10 days - 6 weeks). Approximately 60% of the patients complained of local hypoaesthesia for some weeks; 30% of the patients developed hyperaesthesia, which resolved completely within 6-8 weeks from starting treatment. Loss of bone tissue represented an obstacle to total tissue recovery, but the aesthetic results were satisfactory in nearly all cases.
All patients showed good compliance, both because of the low frequency of medications (at most, twice a week) and because of the painless platelet gel applications. The only negative aspect was abnormal nail growth in a case of distal partial amputation of a finger. In conclusion, we believe that platelet gel can be very useful in patients with traumatic or surgical loss of finger tissue, since it can resolve critical situations thus avoiding amputation of residual tissue and compromised joint function.
自体或同种异体血小板凝胶是一种血液成分,利用血小板α颗粒中包含的细胞因子的作用来刺激修复过程。血小板凝胶的特性最初在慢性溃疡上进行了测试,以加速愈合,后来在矫形、牙科、血管和心胸外科手术中进行了测试。在我们中心,我们已经使用血小板凝胶 5 年了,首先用于有困难伤口的手术患者,然后用于接受骨合成手术的矫形患者和对传统疗法无反应的溃疡患者。随后,我们决定将血小板凝胶的使用也扩展到手指的截肢或创伤性组织损失。
在本文中,我们介绍了在我们的输血医学服务中,使用血小板凝胶治疗 115 例手指截肢或伤口患者的 5 年结果。血小板是从同种异体的富血小板血浆(10 毫升)中获得的,凝胶是通过向浓缩血小板中添加凝血酶来制备的。使用同源血小板凝胶的决定基于其有限的成本、制备的简便性、几乎无限的可用性、可以收集的血小板数量远远高于治疗范围,因此能够替代因辅助药物引起的损失,最后但并非最不重要的是,它不会给患者带来不适。通过包括分子生物学研究在内的病毒学测试确保了产品的安全性。
所有患者的软组织恢复情况在 80%到 100%之间;恢复的中位数时间为 3 周(范围为 10 天至 6 周)。大约 60%的患者会在几周内出现局部感觉迟钝;30%的患者出现感觉过敏,在开始治疗后 6-8 周内完全缓解。骨组织的丢失是完全组织恢复的障碍,但在几乎所有情况下,美学效果都令人满意。
所有患者都表现出良好的依从性,这既是因为药物使用的频率较低(最多每周两次),也是因为无痛的血小板凝胶应用。唯一的负面情况是手指远端部分截肢的情况下指甲生长异常。总之,我们认为血小板凝胶在手指组织创伤或手术丢失的患者中非常有用,因为它可以解决危急情况,从而避免剩余组织的截肢和关节功能受损。